These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression. Thomas J; Alqaisi M; Cunningham P; Carver M; Rebellato L; Gross U; Patselas T; Araneda D; Thomas F Transplantation; 1992 Feb; 53(2):247-58. PubMed ID: 1531393 [TBL] [Abstract][Full Text] [Related]
13. Function and surface phenotype of T lymphocytes infiltrating renal allografts in nonhuman primates treated with monoclonal antibodies. Nocera A; Cosimi AB; Colvin RB; Gesner ML; Fuller TC Transplantation; 1989 Nov; 48(5):732-41. PubMed ID: 2573179 [TBL] [Abstract][Full Text] [Related]
14. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837 [TBL] [Abstract][Full Text] [Related]
15. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Motoyama K; Arima T; Yu S; Lehmann M; Flye MW Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640 [TBL] [Abstract][Full Text] [Related]
16. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression. Trzonkowski P; Zilvetti M; Friend P; Wood KJ Transplantation; 2006 Nov; 82(10):1342-51. PubMed ID: 17130784 [TBL] [Abstract][Full Text] [Related]
17. Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance. Kirk AD; Ibrahim MA; Bollinger RR; Dawson DV; Finn OJ Transplantation; 1992 Feb; 53(2):329-38. PubMed ID: 1371194 [TBL] [Abstract][Full Text] [Related]
18. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872 [TBL] [Abstract][Full Text] [Related]
19. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Arima T; Lehmann M; Flye MW Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332 [TBL] [Abstract][Full Text] [Related]
20. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients. Ruiz P; Fuller J; Sanfilippo F Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]